Research shows that patients with primary aldosteronism who undergo surgery to remove the affected adrenal gland achieve the best outcomes when carefully prepared beforehand with medications that block excess hormone, and then monitored closely after surgery. According to Gram Research analysis, approximately one-third of patients with this hormone imbalance have unilateral disease suitable for surgery, which offers superior long-term results compared to medication alone. Success requires optimizing blood pressure below 140/90 mmHg before surgery, correcting potassium levels, and following a structured postoperative monitoring plan with weekly blood work for the first month and comprehensive evaluation at 6-12 months.
Primary aldosteronism is a hormone condition that causes high blood pressure and is often missed by doctors. About one-third of patients can be cured with surgery to remove part of their adrenal gland. However, surgery requires careful planning before and after to keep patients safe. According to Gram Research analysis, this guide helps endocrinologists prepare patients for surgery, manage them during recovery, and know when they’re truly cured. The key is using specific medications beforehand, monitoring blood pressure and potassium levels, and following up carefully after surgery to catch any problems early.
Key Statistics
A clinical review in Endocrine Connections (2026) found that approximately one-third of patients with primary aldosteronism have unilateral disease suitable for surgical cure, with adrenalectomy offering superior long-term clinical outcomes compared to medical therapy alone.
According to the perioperative management review, preoperative blood pressure optimization to below 140/90 mmHg using mineralocorticoid receptor antagonists is essential before adrenalectomy for primary aldosteronism, with postoperative monitoring including weekly assessments during the first month.
The structured approach recommends comprehensive follow-up evaluation at 6-12 months using PASO criteria, with patients achieving complete biochemical success, clinical response, and classic histopathological features eligible to transition to primary care follow-up.
The Quick Take
- What they studied: How doctors should prepare and care for patients with primary aldosteronism (a hormone imbalance causing high blood pressure) before and after surgery to remove part of their adrenal gland.
- Who participated: This is a clinical guidance document for endocrinologists (hormone specialists) managing patients with primary aldosteronism who are candidates for adrenal surgery.
- Key finding: Patients who receive proper preoperative preparation with specific medications, have surgery to remove the affected adrenal tissue, and follow a structured recovery plan have the best chance of being cured of their high blood pressure.
- What it means for you: If you have primary aldosteronism and are considering surgery, working with an endocrinologist who follows this structured approach—including blood pressure optimization before surgery and careful monitoring after—gives you the best outcome. However, not all patients are candidates for surgery, and some may do well with medication alone.
The Research Details
This is a clinical review article that summarizes best practices for managing patients with primary aldosteronism around the time of surgery. Rather than conducting a new experiment, the authors reviewed existing medical knowledge and guidelines to create a practical step-by-step approach that endocrinologists can follow.
The review covers three main phases: before surgery (preoperative), during surgery, and after surgery (postoperative). For each phase, the authors explain what doctors should do, what medications to use, and what to monitor. This type of guidance document is valuable because it takes complex medical information and organizes it into a clear action plan.
The authors emphasize that while guidelines exist for diagnosing primary aldosteronism and determining which patients need surgery, there hasn’t been much clear guidance on how to manage patients through the surgical process itself. This review fills that gap by providing specific targets (like blood pressure goals) and timelines (like when to check blood work after surgery).
Primary aldosteronism is the most common hormone-related cause of high blood pressure, yet many patients go undiagnosed. For patients who have the type that can be cured with surgery, getting proper perioperative care is crucial. Without good preparation, surgery may not work as well, and patients may experience dangerous side effects after surgery. This structured approach helps ensure that more patients get the right care at the right time.
This is a clinical review article written by endocrinology experts, which means it synthesizes current medical knowledge rather than presenting new research data. The recommendations are based on existing guidelines and clinical experience. While review articles don’t provide the highest level of evidence (that would be large randomized trials), they are valuable for translating research into practical clinical action. Readers should note that this represents expert consensus rather than new experimental findings, and individual patient care should always be personalized by their own medical team.
What the Results Show
The review identifies that approximately one-third of patients with primary aldosteronism have unilateral disease (affecting only one adrenal gland), and these patients benefit most from surgery. Surgery offers better long-term outcomes than medication alone for this group.
Before surgery, the key is preparing the body properly. Doctors should use medications called mineralocorticoid receptor antagonists (MRAs)—think of these as blockers that stop the excess hormone from working. These medications should be adjusted until blood pressure drops below 140/90 mmHg and potassium levels return to normal. This preparation typically takes weeks and is essential for safe surgery.
After surgery, the main concern is that the remaining adrenal gland may not immediately produce the right hormone balance. Doctors need to reduce blood pressure medications, stop the MRA medications, and encourage patients to eat more salt (which seems counterintuitive but helps the body adjust). Blood work should be checked weekly for the first month, then at 6-12 months to determine if the surgery actually cured the condition.
The review emphasizes that true cure means three things: the hormone levels return to normal (biochemical success), blood pressure improves (clinical response), and the tissue removed shows specific features under the microscope (classic histopathology). Patients who achieve all three can often transition to regular primary care follow-up.
The review highlights several important secondary points: First, a dedicated endocrinology consultation before surgery is essential to discuss expected outcomes and prepare for potential complications. Second, doctors need to evaluate whether the patient’s adrenal gland is producing too much cortisol (another hormone), as this affects surgical planning. Third, there’s a risk of postoperative adrenal insufficiency (the remaining gland not producing enough hormones), which requires monitoring. Finally, histological findings (what the tissue looks like under a microscope) help predict whether the condition might return and guide long-term follow-up intensity.
This review builds on existing diagnostic guidelines for primary aldosteronism but fills a specific gap: while previous guidelines explain how to diagnose the condition and decide who needs surgery, they provide limited detail on the actual perioperative management. This structured approach synthesizes current knowledge into a practical framework that goes beyond what was previously available in guideline documents.
As a clinical review rather than a research study, this article doesn’t present new data from patient trials. The recommendations are based on expert consensus and existing evidence, but individual patient outcomes may vary. The review doesn’t quantify success rates or provide statistical comparisons between different management approaches. Additionally, the specific recommendations may need adjustment based on individual patient factors, local practices, and emerging research. Patients should discuss how these general principles apply to their specific situation with their own medical team.
The Bottom Line
For patients with primary aldosteronism who are candidates for surgery: (1) Work with an endocrinologist to prepare for surgery using MRA medications to optimize blood pressure and potassium levels—this is strongly recommended. (2) Have a dedicated preoperative endocrinology consultation to discuss expectations and risks. (3) Follow the structured postoperative monitoring plan with weekly blood work for the first month and comprehensive evaluation at 6-12 months. (4) If you achieve complete biochemical and clinical success with classic tissue findings, you can transition to primary care follow-up. Confidence level: High for the overall approach; individual outcomes vary.
This guidance is primarily for endocrinologists and surgeons managing patients with primary aldosteronism. Patients with primary aldosteronism who are considering surgery should discuss these principles with their care team. Patients with uncontrolled high blood pressure should ask their doctor about screening for primary aldosteronism, as early diagnosis enables better treatment options. Patients already on blood pressure medications who also have low potassium levels should particularly discuss this possibility with their doctor.
Preoperative preparation typically takes 4-8 weeks. Surgery itself is a one-time event. The critical postoperative monitoring period is the first month (weekly blood work), with comprehensive assessment at 6-12 months to determine if surgery was curative. Some patients may see blood pressure improvement within days to weeks after surgery, while others may take months. Complete normalization of hormone levels and blood pressure may take several months. Long-term follow-up depends on whether cure is achieved.
Frequently Asked Questions
What is primary aldosteronism and why is surgery sometimes recommended?
Primary aldosteronism is a hormone imbalance where the adrenal gland produces too much aldosterone, causing high blood pressure and low potassium. About one-third of patients have disease in only one gland, and surgery to remove that gland can cure the condition, offering better long-term results than medication alone.
What medications do doctors use to prepare patients for adrenal surgery?
Doctors use mineralocorticoid receptor antagonists (MRAs), which block the effects of excess aldosterone. These medications lower blood pressure and restore potassium levels before surgery, preparing the body for the procedure and supporting recovery of the remaining adrenal gland.
How long does recovery take after adrenal surgery for primary aldosteronism?
The critical monitoring period is the first month after surgery, with weekly blood work checks. Comprehensive evaluation occurs at 6-12 months to determine if surgery was successful. Some patients see blood pressure improvement within days to weeks, while complete hormone normalization may take several months.
How do doctors know if adrenal surgery actually cured primary aldosteronism?
True cure requires three things: hormone levels return to normal (biochemical success), blood pressure improves (clinical response), and the removed tissue shows specific features under a microscope. Patients meeting all three criteria at 6-12 months can often transition to regular primary care follow-up.
What should patients eat after adrenal surgery for primary aldosteronism?
After surgery, doctors typically recommend a high-sodium diet to help the body adjust as the remaining adrenal gland recovers hormone production. This is temporary and differs from typical high blood pressure dietary advice, so follow your doctor’s specific recommendations.
Want to Apply This Research?
- Track blood pressure readings daily (morning and evening) and potassium levels at scheduled lab visits. Record any changes in blood pressure medications and note when MRA medications are started, adjusted, or stopped. This creates a clear timeline of your preparation and recovery.
- If preparing for surgery: take MRA medications exactly as prescribed, monitor salt intake as directed by your doctor, and attend all preoperative appointments. After surgery: follow the dietary recommendations (including salt intake changes), take medications as adjusted by your doctor, and complete all scheduled blood work and follow-up visits.
- Preoperatively: weekly or biweekly blood pressure checks and monthly lab work to monitor potassium and hormone levels. Postoperatively: daily blood pressure tracking for the first month, weekly clinical check-ins, and comprehensive lab work at 6 weeks, 3 months, and 12 months. Use the app to flag any concerning blood pressure readings or missed appointments.
This article summarizes clinical guidance for healthcare providers managing primary aldosteronism. It is not medical advice for individual patients. If you have primary aldosteronism or suspect you might, consult with an endocrinologist or your primary care physician for personalized evaluation and treatment recommendations. Surgical decisions should only be made after comprehensive diagnostic testing and discussion with your medical team about risks, benefits, and alternatives. Do not start, stop, or adjust any medications without medical supervision.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.